BBI Group acquires Maine Biotechnology Services

The BBI Group, partner to the world’s leading diagnostic and healthcare organisations, has entered into a definitive agreement to acquire the Maine Biotechnology Services, Inc. (MBS) located in Portland, Maine (USA). The acquisition of MBS will expand BBI’s portfolio during a period of expansion and growth. The company provides a range of products to the diagnostic, healthcare, research food sectors globally. MBS will add antibody development to its capability and product range. Lyn Rees, CEO of the BBI Group, said: “The acquisition of MBS perfectly complements our current product portfolio and coincides with our commercial team expansion, giving us important
Read More

Categories: Industry News and News.

Norovirus GI Outbreak

A recent outbreak of a GI strain of Norovirus is further evidence of the importance of having broadly reactive reagents in diagnostic tests.  Only by having antibodies to both GI and the more common GII groups, can a test fully address both food borne and person to person transmitted outbreaks. Sample the most complete Norovirus antibody panel on the market today.   Norovirus Outbreak at Bali Hai in San Diego August 6, 2015 by News Desk 2 Comments A norovirus outbreak has been confirmed at the Bali Hai restaurant in San Diego at a Shelter Island journalism banquet on July
Read More

Categories: Industry News, New Products, and News.

Response to the Antibody Reproducibility Crisis

An article from the May issue of  Nature entitled: Reproducibility Crisis: Blame it on the Antibodies was shared and circulated widely in biotechnology forums and social media platforms.  The widespread interest in the article speaks to the commonly shared industry frustration over antibodies not performing well in end use assays. The explosion of genomic and proteomic medicine over the last few decades has indeed created an insurmountable challenge for the antibody retail sales model. The rapid growth of the number of antibody targets of interest, combined with increasingly nuanced desired epitopes, makes having a comprehensive, well-supported catalog nearly impossible.  As
Read More

Categories: Industry News, New Products, News, and Services.

MBS is exhibiting AACC Clinical Lab Expo in Atlanta, Georgia July 26-30 2015

MBS is exhibiting at the 2015 AACC Clinical Lab Expo in Atlanta, Georgia July 26-30.  MBS is celebrating 25 years in business in 2015. Stop by booth #3758 to discuss your antibody and assay goals with our technical sales team or browse our antibody product catalog.  Our mission is to go beyond limited contract services and be a comprehensive partner in antibody and assay method development.  MBS saves customers money and compresses timelines of the most complex projects.  The cornerstone of antibody and assay development at MBS is our technical team approach to project design and planning. The MBS antibody development plan focuses
Read More

Categories: Industry News, New Products, News, and Services.

MBS Collaborator in the News – Ralph Baric on Controversial Research Policy

How A Tilt Toward Safety Stopped A Scientist’s Virus Research As cases of a worrisome respiratory virus continue to pop up in the Middle East, scientists who study it in the U.S. are struggling to understand how they’ll be affected by a government moratorium on certain kinds of experiments. One of those researchers is Ralph Baric, a virologist at the University of North Carolina School of Medicine in Chapel Hill. “Any virus that has pandemic potential, and that’s any respiratory virus that emerges from animals, is a major public health concern,” Baric says. And Middle East respiratory syndrome, or MERS,
Read More

Categories: Industry News, New Products, and News.